MoneyWorks4Me

The Revenue for the quarter ended  December 2023 of Rs. 1616.99 millions grew by 6.13 % from Rs. 1523.57 millions.The Company's Net profit for the December 2023 quarter have declined marginally to Rs. 157.00  millions as against Rs. 222.83 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 263.99 millions from 338.15 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1616.99 1523.57 6.13 4676.46 4303.51 8.67 6167.34 5201.35 18.57
Other Income 28.70 30.19 -4.94 52.31 44.92 16.45 43.20 27.62 56.41
PBIDT 263.99 338.15 -21.93 727.44 863.36 -15.74 1269.82 1079.38 17.64
Interest 25.56 11.88 115.15 38.38 18.19 111.00 24.14 64.07 -62.32
PBDT 238.43 326.27 -26.92 371.52 845.17 -56.04 1245.68 1015.31 22.69
Depreciation 35.03 30.59 14.51 103.31 89.16 15.87 123.42 100.80 22.44
PBT 203.40 295.68 -31.21 268.21 756.01 -64.52 1122.26 914.51 22.72
TAX 46.40 72.85 -36.31 152.17 194.18 -21.63 288.82 195.04 48.08
Deferred Tax 6.25 8.25 -24.24 16.10 19.09 -15.66 25.05 27.83 -9.99
PAT 157.00 222.83 -29.54 116.04 561.83 -79.35 833.44 719.47 15.84
Equity 368.81 364.37 1.22 368.81 364.37 1.22 364.37 364.37 0.00
PBIDTM(%) 16.33 22.19 -26.44 15.56 20.06 -22.46 20.59 20.75 -0.78
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..